PLUG Plug Power | $1.54
+0.7% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Plug Power (NASDAQ:PLUG) on 3/24/2025 |
CLNN Clene | $3.92
-5.3% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $31.00 -> $31.00 | High | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 3/24/2025 |
BMEA Biomea Fusion | $2.79
-2.8% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 3/24/2025 |
MBRX Moleculin Biotech | $1.06
-2.8% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Moleculin Biotech (NASDAQ:MBRX) on 3/24/2025 |
UBX Unity Biotechnology | $1.30
-28.8% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $8.00 -> $4.00 | N/A | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 3/24/2025 |
AURA Aura Biosciences | $7.00
-6.7% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 3/24/2025 |
ASMB Assembly Biosciences | $11.12
+1.0% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Neutral -> Neutral | | High | View details for HC Wainwright rating of Assembly Biosciences (NASDAQ:ASMB) on 3/24/2025 |
ABEO Abeona Therapeutics | $5.12
-0.6% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 3/24/2025 |
BNTC Benitec Biopharma | $14.34
-11.0% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Benitec Biopharma (NASDAQ:BNTC) on 3/24/2025 |
CGTX Cognition Therapeutics | $0.49
+7.7% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $6.00 -> $5.00 | High | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 3/24/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
ENLV Enlivex Therapeutics | $1.02
-2.4% | 3/24/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $6.00 -> $7.00 | High | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 3/24/2025 |
RMTI Rockwell Medical | $1.26
-6.7% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $7.00 -> $3.00 | High | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 3/24/2025 |
RYTM Rhythm Pharmaceuticals | $53.72
+3.2% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $70.00 -> $70.00 | High | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 3/24/2025 |
FLUX Flux Power | $2.10
+7.7% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $15.00 -> $8.00 | High | View details for HC Wainwright rating of Flux Power (NASDAQ:FLUX) on 3/24/2025 |
PHUN Phunware | $3.07
+4.1% | 3/24/2025 | Target Lowered by | HC Wainwright | Analyst S. Buck | Neutral -> Neutral | $6.00 -> $3.00 | Medium | View details for HC Wainwright rating of Phunware (NASDAQ:PHUN) on 3/24/2025 |
COLL Collegium Pharmaceutical | $30.56
+1.7% | 3/24/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $50.00 -> $50.00 | High | View details for HC Wainwright rating of Collegium Pharmaceutical (NASDAQ:COLL) on 3/24/2025 |
VSTM Verastem | $6.88
+3.5% | 3/24/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $7.00 -> $10.00 | Medium | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 3/24/2025 |
MTVA MetaVia | $1.58
+1.9% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of MetaVia (NASDAQ:MTVA) on 3/21/2025 |
BRNS Barinthus Biotherapeutics | $1.03
+4.0% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 3/21/2025 |
YMAB Y-mAbs Therapeutics | $5.16
+3.2% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $22.00 -> $12.00 | Medium | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 3/21/2025 |
LGVN Longeveron | $1.86
+0.5% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 3/21/2025 |
EBS Emergent BioSolutions | $5.74
+0.3% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Emergent BioSolutions (NYSE:EBS) on 3/21/2025 |
ERAS Erasca | $1.49
-2.6% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 3/21/2025 |
MOGO Mogo | $0.98
+3.2% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $6.00 -> $4.00 | Low | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 3/21/2025 |
IDN Intellicheck | $2.69
-1.1% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 3/21/2025 |
PPTA Perpetua Resources | $11.15
-0.4% | 3/21/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $25.00 -> $28.00 | High | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 3/21/2025 |
UAMY United States Antimony | $2.23
+5.7% | 3/21/2025 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $2.50 -> $2.60 | High | View details for HC Wainwright rating of United States Antimony (NYSE:UAMY) on 3/21/2025 |
AMPX Amprius Technologies | $3.30
+5.9% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Amprius Technologies (NYSE:AMPX) on 3/21/2025 |
CBUS Cibus | $2.20
+7.3% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Cibus (NASDAQ:CBUS) on 3/21/2025 |
VALN Valneva | $7.43
+3.6% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $17.00 -> $17.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 3/21/2025 |
IFRX InflaRx | $1.41
+10.2% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 3/21/2025 |
ELEV Elevation Oncology | $0.29
-3.4% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $1.00 | High | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 3/21/2025 |
VOR Vor Biopharma | $0.88
+1.7% | 3/21/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $17.50 -> $13.00 | High | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 3/21/2025 |
CNTX Context Therapeutics | $0.76
-1.0% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Context Therapeutics (NASDAQ:CNTX) on 3/21/2025 |
ELVN Enliven Therapeutics | $22.46
+6.5% | 3/21/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $37.00 -> $39.00 | High | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 3/21/2025 |
OPTN OptiNose | $9.17
+0.2% | 3/21/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Neutral | $18.00 -> $9.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 3/21/2025 |
AVTX Avalo Therapeutics | $7.63
-0.4% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | Low | View details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 3/20/2025 |
ESPR Esperion Therapeutics | $1.74
+3.0% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 3/20/2025 |
PHAR Pharming Group | $8.76
-1.0% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $37.00 -> $37.00 | Low | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 3/20/2025 |
PGEN Precigen | $1.82
+0.6% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 3/20/2025 |
Wall Street's Algorithms Are Making One-Sided Trades (Here's How to Spot Them) (Ad) Have you noticed how certain stocks move in unnaturally straight lines lately? I watched CAKE last week steadily decline day after day in an almost perfect downward channel. Click here to discover how the Genesis Cog works in falling markets |
SCPH scPharmaceuticals | $3.13
+4.3% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of scPharmaceuticals (NASDAQ:SCPH) on 3/20/2025 |
MDWD MediWound | $16.45
+1.1% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 3/20/2025 |
KRRO Korro Bio | $24.03
+1.1% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $115.00 -> $115.00 | High | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 3/20/2025 |
ALMS Alumis | $3.78
+0.8% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $19.00 -> $15.00 | High | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 3/20/2025 |
LQDA Liquidia | $15.66
+3.6% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $29.00 -> $29.00 | High | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 3/20/2025 |
PMVP PMV Pharmaceuticals | $1.24
-2.4% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 3/20/2025 |
NRXP NRx Pharmaceuticals | $2.07
-0.5% | 3/20/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/20/2025 |
FEMY Femasys | $1.56
-2.5% | 3/19/2025 | Target Raised by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $15.00 | Medium | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/19/2025 |
DTIL Precision BioSciences | $5.64
+3.5% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $60.00 | Low | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 3/19/2025 |
ATAI Atai Life Sciences | $1.57
+8.3% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 3/19/2025 |
IMVT Immunovant | $19.44
-1.0% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $51.00 -> $51.00 | High | View details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 3/19/2025 |
MUX McEwen Mining | $7.76
+1.4% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of McEwen Mining (NYSE:MUX) on 3/19/2025 |
STOK Stoke Therapeutics | $8.29
+1.7% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $47.00 -> $47.00 | High | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 3/19/2025 |
REE REE Automotive | $3.97
+2.6% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 3/19/2025 |
GAU Galiano Gold | $1.24
-0.8% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.80 -> $2.80 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 3/19/2025 |
OLMA Olema Pharmaceuticals | $4.32
+2.1% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 3/19/2025 |
OABI OmniAb | $2.54
+0.4% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of OmniAb (NASDAQ:OABI) on 3/19/2025 |
XOMA XOMA | $20.93
+0.2% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $104.00 -> $104.00 | High | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 3/19/2025 |
TRVI Trevi Therapeutics | $6.40
-1.1% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $12.50 -> $12.50 | High | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/19/2025 |
ETON Eton Pharmaceuticals | $14.79
+4.0% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $33.00 -> $33.00 | Low | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 3/19/2025 |
PYXS Pyxis Oncology | $1.20
-0.8% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 3/19/2025 |
ABSI Absci | $3.10
+3.0% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 3/19/2025 |
DMAC DiaMedica Therapeutics | $4.95
-0.6% | 3/19/2025 | Target Raised by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $7.00 -> $10.00 | Low | View details for HC Wainwright rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 3/19/2025 |
INO Inovio Pharmaceuticals | $1.88
-2.1% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Neutral -> Neutral | $3.00 -> $3.00 | High | View details for HC Wainwright rating of Inovio Pharmaceuticals (NASDAQ:INO) on 3/19/2025 |
ASRT Assertio | $0.76
+4.7% | 3/19/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $4.00 -> $3.50 | High | View details for HC Wainwright rating of Assertio (NASDAQ:ASRT) on 3/19/2025 |
SRPT Sarepta Therapeutics | $76.33
+3.0% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $75.00 -> $75.00 | High | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/19/2025 |
PRME Prime Medicine | $2.03
+4.1% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Prime Medicine (NYSE:PRME) on 3/19/2025 |
CRBU Caribou Biosciences | $1.02
-1.9% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $9.00 -> $9.00 | High | View details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 3/19/2025 |
CATX Perspective Therapeutics | $2.52
| 3/19/2025 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Perspective Therapeutics (NYSE:CATX) on 3/19/2025 |
ALLO Allogene Therapeutics | $1.68
+3.7% | 3/19/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $9.00 -> $8.00 | High | View details for HC Wainwright rating of Allogene Therapeutics (NASDAQ:ALLO) on 3/19/2025 |
OPK OPKO Health | $1.81
+0.6% | 3/19/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 3/19/2025 |
ATNM Actinium Pharmaceuticals | $1.49
-3.9% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 3/18/2025 |
INKT MiNK Therapeutics | $8.57
-5.8% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $35.00 -> $35.00 | High | View details for HC Wainwright rating of MiNK Therapeutics (NASDAQ:INKT) on 3/18/2025 |
HROW Harrow | $30.00
+5.6% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $57.00 -> $57.00 | High | View details for HC Wainwright rating of Harrow (NASDAQ:HROW) on 3/18/2025 |
BTM Bitcoin Depot | $1.48
+8.8% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of Bitcoin Depot (NASDAQ:BTM) on 3/18/2025 |
FGEN FibroGen | $0.37
+17.1% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst M. Keller | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of FibroGen (NASDAQ:FGEN) on 3/18/2025 |
ENTX Entera Bio | $1.95
| 3/18/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 3/18/2025 |
PLRX Pliant Therapeutics | $1.59
+2.6% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral -> Neutral | | High | View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 3/18/2025 |
ELBM Electra Battery Materials | $1.15
-6.5% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.40 -> $2.40 | High | View details for HC Wainwright rating of Electra Battery Materials (NASDAQ:ELBM) on 3/18/2025 |
EU enCore Energy | $1.63
-1.2% | 3/18/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.00 -> $2.75 | Low | View details for HC Wainwright rating of enCore Energy (NASDAQ:EU) on 3/18/2025 |
USAS Americas Silver | $0.56
-1.0% | 3/18/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.00 -> $0.90 | N/A | View details for HC Wainwright rating of Americas Silver (NYSEAMERICAN:USAS) on 3/18/2025 |
SUUN SolarBank | $3.04
-5.6% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of SolarBank (NASDAQ:SUUN) on 3/18/2025 |
ACOG Alpha Cognition | $5.33
-0.7% | 3/18/2025 | Initiated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy | $20.00 | Medium | View details for HC Wainwright rating of Alpha Cognition (NASDAQ:ACOG) on 3/18/2025 |
ALT Altimmune | $6.05
+4.1% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 3/18/2025 |
GOSS Gossamer Bio | $1.28
-7.9% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 3/18/2025 |
BLTE Belite Bio | $66.94
-0.5% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $100.00 -> $100.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 3/18/2025 |
SANA Sana Biotechnology | $2.42
+4.8% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 3/18/2025 |
AGEN Agenus | $1.64
+1.9% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 3/18/2025 |
MDAI Spectral AI | $1.49
-12.4% | 3/18/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $3.50 -> $3.50 | High | View details for HC Wainwright rating of Spectral AI (NASDAQ:MDAI) on 3/18/2025 |
OKUR OnKure Therapeutics | $4.96
-1.8% | 3/18/2025 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $40.00 -> $34.00 | High | View details for HC Wainwright rating of OnKure Therapeutics (NASDAQ:OKUR) on 3/18/2025 |
Your Wealth is Under Attack (Ad) Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold. Click here now to see how to stop them in their tracks! |
BDTX Black Diamond Therapeutics | $1.68
-5.6% | 3/18/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $11.00 -> $12.00 | High | View details for HC Wainwright rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/18/2025 |
CAPR Capricor Therapeutics | $13.28
+3.3% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $77.00 -> $77.00 | High | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 3/17/2025 |
DYN Dyne Therapeutics | $12.39
+2.6% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 3/17/2025 |
DRTS Alpha Tau Medical | $2.70
+3.4% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $9.00 -> $9.00 | Low | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 3/17/2025 |
NXTC NextCure | $0.61
+6.8% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 3/17/2025 |
MIST Milestone Pharmaceuticals | $2.05
+7.9% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 3/17/2025 |
RNA Avidity Biosciences | $33.30
+8.0% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst A. Ghosh | Buy -> Buy | $72.00 -> $72.00 | High | View details for HC Wainwright rating of Avidity Biosciences (NASDAQ:RNA) on 3/17/2025 |
STRO Sutro Biopharma | $0.77
+0.4% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Neutral | $12.00 -> $2.00 | High | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 3/17/2025 |
BTBT Bit Digital | $2.49
+6.9% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 3/17/2025 |
VERI Veritone | $2.76
| 3/17/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Veritone (NASDAQ:VERI) on 3/17/2025 |
ANIP ANI Pharmaceuticals | $65.98
+2.7% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $94.00 -> $94.00 | High | View details for HC Wainwright rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/17/2025 |
GANX Gain Therapeutics | $2.32
-0.9% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 3/17/2025 |
RGNX REGENXBIO | $8.70
+5.6% | 3/17/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $36.00 -> $34.00 | Medium | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 3/17/2025 |
ZNTL Zentalis Pharmaceuticals | $1.98
+3.7% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 3/17/2025 |
RLYB Rallybio | $0.61
-9.3% | 3/17/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 3/17/2025 |
ACTU Actuate Therapeutics | $7.20
+6.7% | 3/17/2025 | Initiated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy | $20.00 | Low | View details for HC Wainwright rating of Actuate Therapeutics (NASDAQ:ACTU) on 3/17/2025 |
NRXP NRx Pharmaceuticals | $2.07
-0.5% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/14/2025 |
CADL Candel Therapeutics | $8.66
+7.4% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $19.00 -> $19.00 | High | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 3/14/2025 |
AKBA Akebia Therapeutics | $2.04
-4.2% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $7.50 -> $7.50 | High | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 3/14/2025 |
INAB IN8bio | $0.23
-2.1% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $6.00 | Medium | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 3/14/2025 |
RNAC Cartesian Therapeutics | $15.94
-0.7% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $45.00 -> $40.00 | High | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 3/14/2025 |
PRQR ProQR Therapeutics | $1.65
| 3/14/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $10.00 -> $12.00 | High | View details for HC Wainwright rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2025 |
ACIU AC Immune | $2.12
+1.0% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 3/14/2025 |
KALV KalVista Pharmaceuticals | $12.25
+3.0% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 3/14/2025 |
VIGL Vigil Neuroscience | $1.90
+0.5% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $17.00 -> $14.00 | High | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 3/14/2025 |
EMX EMX Royalty | $1.93
+0.5% | 3/14/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.00 -> $5.00 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 3/14/2025 |
AMTX Aemetis | $2.01
| 3/14/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Aemetis (NASDAQ:AMTX) on 3/14/2025 |
SOL Emeren Group | $1.68
+0.9% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Emeren Group (NYSE:SOL) on 3/14/2025 |
BLNK Blink Charging | $1.03
+4.0% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Sameer Joshi | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 3/14/2025 |
PHAR Pharming Group | $8.76
-1.0% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $37.00 -> $37.00 | Medium | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 3/14/2025 |
ATYR Atyr PHARMA | $3.70
+0.5% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $35.00 -> $35.00 | Medium | View details for HC Wainwright rating of Atyr PHARMA (NASDAQ:ATYR) on 3/14/2025 |
TRML Tourmaline Bio | $17.61
+2.7% | 3/14/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $49.00 -> $50.00 | High | View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 3/14/2025 |
LYRA Lyra Therapeutics | $0.16
-6.8% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Neutral -> Neutral | $2.00 -> $2.00 | High | View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 3/14/2025 |
RGLS Regulus Therapeutics | $1.44
+5.1% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/14/2025 |
IPA ImmunoPrecise Antibodies | $0.43
+1.6% | 3/14/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 3/14/2025 |
PDSB PDS Biotechnology | $1.37
| 3/13/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $21.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/13/2025 |
IBRX ImmunityBio | $2.85
+5.2% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 3/13/2025 |
FEMY Femasys | $1.56
-2.5% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/13/2025 |
NKTR Nektar Therapeutics | $0.86
-0.4% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $6.50 -> $6.50 | High | View details for HC Wainwright rating of Nektar Therapeutics (NASDAQ:NKTR) on 3/13/2025 |
UEC Uranium Energy | $5.53
| 3/13/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $12.25 -> $12.25 | N/A | View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 3/13/2025 |
VYGR Voyager Therapeutics | $3.91
+0.8% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/13/2025 |
AEYE AudioEye | $12.18
+6.9% | 3/13/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $37.00 -> $22.00 | High | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 3/13/2025 |
VANI Vivani Medical | $1.09
| 3/13/2025 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 3/13/2025 |
OCS Oculis | $19.61
+0.2% | 3/13/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $30.00 -> $29.00 | Low | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 3/13/2025 |
ZVRA Zevra Therapeutics | $8.21
+2.5% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/13/2025 |
LYEL Lyell Immunopharma | $0.56
-3.3% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | $1.00 -> $1.00 | High | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 3/13/2025 |
EDSA Edesa Biotech | $2.56
+2.4% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $21.00 -> $21.00 | Medium | View details for HC Wainwright rating of Edesa Biotech (NASDAQ:EDSA) on 3/13/2025 |
ECOR electroCore | $7.43
-7.1% | 3/13/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of electroCore (NASDAQ:ECOR) on 3/13/2025 |
CATX Perspective Therapeutics | $2.52
| 3/13/2025 | Initiated by | HC Wainwright | Analyst Robert Burns | Buy | $10.00 | High | View details for HC Wainwright rating of Perspective Therapeutics (NYSE:CATX) on 3/13/2025 |
ASM Avino Silver & Gold Mines | $1.77
-7.1% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.90 -> $2.20 | High | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/12/2025 |
Your Wealth is Under Attack (Ad) Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold. Click here now to see how to stop them in their tracks! |
ASM Avino Silver & Gold Mines | $1.78
-0.6% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.90 -> $2.20 | High | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/12/2025 |
OPK OPKO Health | $1.81
+0.6% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $3.00 -> $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 3/12/2025 |
CLNN Clene | $3.92
-5.3% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 3/12/2025 |
LEGN Legend Biotech | $36.33
-1.7% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $73.00 -> $75.00 | Medium | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 3/12/2025 |
HUMA Humacyte | $3.32
| 3/12/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 3/12/2025 |
EVEX EVE | $3.70
+3.3% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of EVE (NYSE:EVEX) on 3/12/2025 |
RDW Redwire | $11.49
+0.1% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $26.00 -> $26.00 | High | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 3/12/2025 |
EXK Endeavour Silver | $4.65
-0.3% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.00 -> $7.25 | High | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 3/12/2025 |
DNTH Dianthus Therapeutics | $19.41
-0.4% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/12/2025 |
MYO Myomo | $5.52
+2.6% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $7.50 -> $9.50 | N/A | View details for HC Wainwright rating of Myomo (NYSEAMERICAN:MYO) on 3/12/2025 |
IMCR Immunocore | $29.64
-0.6% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $100.00 -> $100.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 3/12/2025 |
GERN Geron | $1.75
-3.8% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Geron (NASDAQ:GERN) on 3/12/2025 |
AGEN Agenus | $1.64
+1.9% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 3/12/2025 |
ATOS Atossa Therapeutics | $0.75
-0.5% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 3/12/2025 |
MURA Mural Oncology | $3.83
-0.5% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for HC Wainwright rating of Mural Oncology (NASDAQ:MURA) on 3/12/2025 |
HOWL Werewolf Therapeutics | $1.12
-0.9% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for HC Wainwright rating of Werewolf Therapeutics (NASDAQ:HOWL) on 3/12/2025 |
CRBP Corbus Pharmaceuticals | $5.96
+3.7% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $75.00 -> $50.00 | Low | View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/12/2025 |
BWAY BrainsWay | $9.77
-1.4% | 3/12/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 3/12/2025 |
ZYXI Zynex | $2.59
+5.7% | 3/12/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $17.00 -> $15.00 | High | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 3/12/2025 |
LFMD LifeMD | $6.10
+8.9% | 3/12/2025 | Target Raised by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $12.00 -> $14.00 | Medium | View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 3/12/2025 |
SGMT Sagimet Biosciences | $4.13
+3.5% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $32.00 -> $32.00 | Low | View details for HC Wainwright rating of Sagimet Biosciences (NASDAQ:SGMT) on 3/11/2025 |
JSPR Jasper Therapeutics | $5.24
+0.6% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/11/2025 |
ATXS Astria Therapeutics | $6.37
-0.6% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 3/11/2025 |
CORZ Core Scientific | $9.31
+9.4% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for HC Wainwright rating of Core Scientific (NASDAQ:CORZ) on 3/11/2025 |
OLMA Olema Pharmaceuticals | $4.32
+2.1% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 3/11/2025 |
AA Alcoa | $33.50
-1.3% | 3/11/2025 | Target Raised by | HC Wainwright | - | Buy | $90.00 | Low | View details for HC Wainwright rating of Alcoa (NYSE:AA) on 3/11/2025 |
ARVN Arvinas | $8.61
-1.6% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $81.00 -> $81.00 | High | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 3/11/2025 |
VKTX Viking Therapeutics | $29.28
+1.1% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $102.00 -> $102.00 | High | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/11/2025 |
ATNM Actinium Pharmaceuticals | $1.49
-3.9% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 3/11/2025 |
ALGS Aligos Therapeutics | $11.63
+8.2% | 3/11/2025 | Target Lowered by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $75.00 -> $70.00 | Low | View details for HC Wainwright rating of Aligos Therapeutics (NASDAQ:ALGS) on 3/11/2025 |
FNV Franco-Nevada | $155.76
0.0% | 3/11/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $155.00 -> $165.00 | Low | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 3/11/2025 |
WWR Westwater Resources | $0.62
+1.7% | 3/11/2025 | Initiated by | HC Wainwright | Analyst Heiko Ihle | Buy | $2.50 | High | View details for HC Wainwright rating of Westwater Resources (NASDAQ:WWR) on 3/11/2025 |
INUV Inuvo | $0.42
-3.4% | 3/11/2025 | Initiated by | HC Wainwright | Analyst Scott Buck | Buy | $2.00 | Low | View details for HC Wainwright rating of Inuvo (NYSE:INUV) on 3/11/2025 |
CHRS Coherus BioSciences | $0.95
-7.6% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 3/11/2025 |
TNYA Tenaya Therapeutics | $0.70
+10.0% | 3/11/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $18.00 -> $5.00 | High | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/11/2025 |
LCTX Lineage Cell Therapeutics | $0.54
+5.9% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/11/2025 |
CKPT Checkpoint Therapeutics | $4.05
-0.5% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Neutral | $4.10 | Low | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/11/2025 |
INZY Inozyme Pharma | $1.01
+3.7% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Inozyme Pharma (NASDAQ:INZY) on 3/11/2025 |
LFWD ReWalk Robotics | $1.80
+4.7% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:LFWD) on 3/11/2025 |
ENGN enGene | $4.63
-6.7% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 3/11/2025 |
URGN UroGen Pharma | $11.90
-1.9% | 3/11/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $64.00 -> $55.00 | High | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 3/11/2025 |
FENC Fennec Pharmaceuticals | $6.60
-1.0% | 3/11/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 3/11/2025 |
TRVI Trevi Therapeutics | $6.40
-1.1% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $7.50 -> $12.50 | High | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/10/2025 |
ONCY Oncolytics Biotech | $0.63
-0.1% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 3/10/2025 |
ZYME Zymeworks | $13.05
+2.6% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Neutral -> Neutral | $12.00 -> $13.00 | Low | View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 3/10/2025 |
MLYS Mineralys Therapeutics | $16.17
-4.1% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 3/10/2025 |
BEAM Beam Therapeutics | $24.01
+3.0% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 3/10/2025 |
JAZZ Jazz Pharmaceuticals | $142.02
+2.3% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $200.00 -> $217.00 | Low | View details for HC Wainwright rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/10/2025 |
CDTX Cidara Therapeutics | $23.63
+5.2% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $24.00 -> $35.00 | High | View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 3/10/2025 |
GEVO Gevo | $1.30
-0.8% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 3/10/2025 |
3 Under-$10 Stocks That Could Skyrocket (Ad) Looking for affordable stocks that could deliver big returns? Our latest report showcases 3 buy-rated stocks under $10 that analysts believe have major upside potential. Don’t miss out on these hidden opportunities that could boost your portfolio. Download Your Free Report Today. |
PTGX Protagonist Therapeutics | $52.53
-0.2% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $54.00 -> $54.00 | High | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 3/10/2025 |
ELEV Elevation Oncology | $0.29
-3.4% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 3/10/2025 |
SLDB Solid Biosciences | $4.78
+3.9% | 3/10/2025 | Target Raised by | HC Wainwright | Analyst Arthur He | Buy -> Buy | $16.00 -> $20.00 | High | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 3/10/2025 |
UBX Unity Biotechnology | $1.30
-28.8% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 3/10/2025 |
ALMS Alumis | $3.78
+0.8% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $19.00 -> $19.00 | Low | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 3/10/2025 |
AQST Aquestive Therapeutics | $3.25
+1.2% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 3/10/2025 |
RAPT RAPT Therapeutics | $1.53
+16.8% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 3/10/2025 |
NUVB Nuvation Bio | $1.96
+3.4% | 3/10/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $11.00 -> $10.00 | High | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 3/10/2025 |
OBIO Orchestra BioMed | $4.57
+1.3% | 3/10/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Orchestra BioMed (NASDAQ:OBIO) on 3/10/2025 |
IFRX InflaRx | $1.41
+10.2% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 3/7/2025 |
ARCT Arcturus Therapeutics | $13.27
+3.0% | 3/7/2025 | Target Lowered by | HC Wainwright | Analyst Ed Arce | Buy -> Buy | $63.00 -> $60.00 | High | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 3/7/2025 |
PDSB PDS Biotechnology | $1.37
| 3/7/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $21.00 -> $21.00 | High | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/7/2025 |
BKSY BlackSky Technology | $9.29
+6.6% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of BlackSky Technology (NYSE:BKSY) on 3/7/2025 |
BBAI BigBear.ai | $3.57
+20.0% | 3/7/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $7.00 -> $6.00 | High | View details for HC Wainwright rating of BigBear.ai (NYSE:BBAI) on 3/7/2025 |
SRFM Surf Air Mobility | $3.82
+2.7% | 3/7/2025 | Initiated by | HC Wainwright | Analyst Amit Dayal | Buy | $12.00 | High | View details for HC Wainwright rating of Surf Air Mobility (NYSE:SRFM) on 3/7/2025 |
GORO Gold Resource | $0.55
+1.0% | 3/7/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $1.75 -> $1.25 | High | View details for HC Wainwright rating of Gold Resource (NYSE:GORO) on 3/7/2025 |
XERS Xeris Biopharma | $5.87
+1.0% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Oren Livnat | Buy -> Buy | $6.60 -> $8.00 | High | View details for HC Wainwright rating of Xeris Biopharma (NASDAQ:XERS) on 3/7/2025 |
PHAT Phathom Pharmaceuticals | $6.55
+5.1% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 3/7/2025 |
SLN Silence Therapeutics | $3.49
-2.0% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $75.00 -> $75.00 | High | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 3/7/2025 |
MNMD Mind Medicine (MindMed) | $6.92
+3.0% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $55.00 -> $55.00 | Medium | View details for HC Wainwright rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 3/7/2025 |
ALXO ALX Oncology | $0.69
-2.4% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 3/7/2025 |
DCTH Delcath Systems | $13.96
+1.7% | 3/7/2025 | Target Raised by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $22.00 -> $24.00 | High | View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 3/7/2025 |
FHTX Foghorn Therapeutics | $4.22
+4.2% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 3/7/2025 |
ACET Adicet Bio | $0.91
+19.3% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 3/7/2025 |
NXTC NextCure | $0.61
+6.8% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $4.00 -> $3.00 | High | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 3/7/2025 |
CTMX CytomX Therapeutics | $0.67
+0.5% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Neutral | | High | View details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 3/7/2025 |
AVBP ArriVent BioPharma | $20.21
+3.5% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $39.00 -> $39.00 | High | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 3/7/2025 |
RLAY Relay Therapeutics | $3.10
+1.3% | 3/7/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 3/7/2025 |
RPTX Repare Therapeutics | $1.08
-3.6% | 3/7/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $10.00 -> $5.00 | Low | View details for HC Wainwright rating of Repare Therapeutics (NASDAQ:RPTX) on 3/7/2025 |
VYNE VYNE Therapeutics | $1.75
+1.7% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $5.75 -> $5.75 | Low | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 3/6/2025 |
CLSD Clearside Biomedical | $1.03
+2.5% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $6.00 -> $6.00 | Medium | View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 3/6/2025 |
BLFS BioLife Solutions | $26.41
+5.7% | 3/6/2025 | Target Raised by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $27.00 -> $30.00 | Low | View details for HC Wainwright rating of BioLife Solutions (NASDAQ:BLFS) on 3/6/2025 |
BWEN Broadwind | $1.43
-0.7% | 3/6/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $8.00 -> $6.00 | Medium | View details for HC Wainwright rating of Broadwind (NASDAQ:BWEN) on 3/6/2025 |
ALTO Alto Ingredients | $1.31
-3.7% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $5.50 -> $5.50 | High | View details for HC Wainwright rating of Alto Ingredients (NASDAQ:ALTO) on 3/6/2025 |
FTEK Fuel Tech | $1.00
+3.5% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of Fuel Tech (NASDAQ:FTEK) on 3/6/2025 |
ITOS iTeos Therapeutics | $6.89
+0.1% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $46.00 -> $46.00 | Low | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 3/6/2025 |
OCGN Ocugen | $0.64
+5.4% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 3/6/2025 |
EYPT EyePoint Pharmaceuticals | $6.34
+1.4% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 3/6/2025 |
TCRX TScan Therapeutics | $1.60
-4.2% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 3/6/2025 |
KMDA Kamada | $7.10
+5.7% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Kamada (NASDAQ:KMDA) on 3/6/2025 |
TARA Protara Therapeutics | $4.70
+2.2% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $23.00 -> $23.00 | High | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 3/6/2025 |
HALO Halozyme Therapeutics | $64.02
-1.7% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | | Low | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 3/6/2025 |
CING Cingulate | $3.94
-0.5% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of Cingulate (NASDAQ:CING) on 3/6/2025 |
AXSM Axsome Therapeutics | $129.17
+1.9% | 3/6/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $200.00 -> $200.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 3/6/2025 |
IBRX ImmunityBio | $2.85
+5.2% | 3/6/2025 | Initiated by | HC Wainwright | Analyst Andrew Fein | Buy | $8.00 | Low | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 3/6/2025 |
OLMA Olema Pharmaceuticals | $4.32
+2.1% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 3/5/2025 |
CMRX Chimerix | $8.50
| 3/5/2025 | Reiterated by | HC Wainwright | Analyst Edward White | Buy -> Neutral | $11.00 -> $8.55 | High | View details for HC Wainwright rating of Chimerix (NASDAQ:CMRX) on 3/5/2025 |
BTCM BIT Mining | $1.92
+1.1% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Neutral -> Neutral | | High | View details for HC Wainwright rating of BIT Mining (NYSE:BTCM) on 3/5/2025 |
PLUG Plug Power | $1.54
+0.7% | 3/5/2025 | Target Lowered by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $5.00 -> $3.00 | High | View details for HC Wainwright rating of Plug Power (NASDAQ:PLUG) on 3/5/2025 |
EOLS Evolus | $13.00
-0.2% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $27.00 -> $27.00 | Medium | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 3/5/2025 |
RIGL Rigel Pharmaceuticals | $20.54
+1.7% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $57.00 -> $57.00 | High | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 3/5/2025 |
IOBT IO Biotech | $1.00
+4.2% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of IO Biotech (NASDAQ:IOBT) on 3/5/2025 |
SENS Senseonics | $0.75
+0.9% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Vernon Bernardino | Buy -> Buy | $2.00 -> $2.00 | Medium | View details for HC Wainwright rating of Senseonics (NYSE:SENS) on 3/5/2025 |
TIL Instil Bio | $19.51
+9.1% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $110.00 -> $110.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 3/5/2025 |
WVE Wave Life Sciences | $10.07
+5.0% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Wave Life Sciences (NASDAQ:WVE) on 3/5/2025 |
AMLX Amylyx Pharmaceuticals | $3.78
+3.6% | 3/5/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 3/5/2025 |
NTLA Intellia Therapeutics | $9.31
+3.4% | 3/5/2025 | Initiated by | HC Wainwright | Analyst Mitchell Kapoor | Buy | $30.00 | Low | View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 3/5/2025 |
CAPR Capricor Therapeutics | $13.28
+3.3% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $77.00 -> $77.00 | High | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 3/4/2025 |
QURE uniQure | $14.77
+7.8% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $70.00 -> $70.00 | High | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 3/4/2025 |
CMPS COMPASS Pathways | $3.11
+0.3% | 3/4/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $45.00 -> $45.00 | Medium | View details for HC Wainwright rating of COMPASS Pathways (NASDAQ:CMPS) on 3/4/2025 |
